These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
470 related articles for article (PubMed ID: 27855500)
1. Treatment of hepatitis B virus: an update. Ward H; Tang L; Poonia B; Kottilil S Future Microbiol; 2016 Dec; 11(12):1581-1597. PubMed ID: 27855500 [TBL] [Abstract][Full Text] [Related]
2. Upcoming pharmacological developments in chronic hepatitis B: can we glimpse a cure on the horizon? Alonso S; Guerra AR; Carreira L; Ferrer JÁ; Gutiérrez ML; Fernandez-Rodriguez CM BMC Gastroenterol; 2017 Dec; 17(1):168. PubMed ID: 29268704 [TBL] [Abstract][Full Text] [Related]
3. Latest developments in the treatment of hepatitis B. Dandri M; Petersen J Minerva Gastroenterol Dietol; 2016 Mar; 62(1):88-102. PubMed ID: 26448309 [TBL] [Abstract][Full Text] [Related]
4. An Effective Antiviral Approach Targeting Hepatitis B Virus with NJK14047, a Novel and Selective Biphenyl Amide p38 Mitogen-Activated Protein Kinase Inhibitor. Kim SY; Kim H; Kim SW; Lee NR; Yi CM; Heo J; Kim BJ; Kim NJ; Inn KS Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559272 [TBL] [Abstract][Full Text] [Related]
5. Antiviral strategies to eliminate hepatitis B virus covalently closed circular DNA (cccDNA). Revill P; Locarnini S Curr Opin Pharmacol; 2016 Oct; 30():144-150. PubMed ID: 27639371 [TBL] [Abstract][Full Text] [Related]
6. New antivirals for the treatment of chronic hepatitis B. Soriano V; Barreiro P; Benitez L; Peña JM; de Mendoza C Expert Opin Investig Drugs; 2017 Jul; 26(7):843-851. PubMed ID: 28521532 [TBL] [Abstract][Full Text] [Related]
7. Predictive value of intrahepatic hepatitis B virus covalently closed circular DNA and total DNA in patients with acute hepatitis B and patients with chronic hepatitis B receiving anti‑viral treatment. Ruan P; Zhou B; Dai X; Sun Z; Guo X; Huang J; Gong Z Mol Med Rep; 2014 Apr; 9(4):1135-41. PubMed ID: 24566465 [TBL] [Abstract][Full Text] [Related]
8. Virological Basis for the Cure of Chronic Hepatitis B. Hu J; Cheng J; Tang L; Hu Z; Luo Y; Li Y; Zhou T; Chang J; Guo JT ACS Infect Dis; 2019 May; 5(5):659-674. PubMed ID: 29893548 [TBL] [Abstract][Full Text] [Related]
9. The current status and future directions of hepatitis B antiviral drug discovery. Tang L; Zhao Q; Wu S; Cheng J; Chang J; Guo JT Expert Opin Drug Discov; 2017 Jan; 12(1):5-15. PubMed ID: 27797587 [TBL] [Abstract][Full Text] [Related]
10. Metabolism and function of hepatitis B virus cccDNA: Implications for the development of cccDNA-targeting antiviral therapeutics. Guo JT; Guo H Antiviral Res; 2015 Oct; 122():91-100. PubMed ID: 26272257 [TBL] [Abstract][Full Text] [Related]
11. Serum hepatitis B surface antigen quantitation can reflect hepatitis B virus in the liver and predict treatment response. Chan HL; Wong VW; Tse AM; Tse CH; Chim AM; Chan HY; Wong GL; Sung JJ Clin Gastroenterol Hepatol; 2007 Dec; 5(12):1462-8. PubMed ID: 18054753 [TBL] [Abstract][Full Text] [Related]
12. Inhibiting the Secretion of Hepatitis B Surface Antigen (HBsAg) to Treat Hepatitis B Infection- a Review. Baugh SDP Infect Disord Drug Targets; 2017; 17(1):24-35. PubMed ID: 28056752 [TBL] [Abstract][Full Text] [Related]
16. Eradication Strategies for Chronic Hepatitis B Infection. Wilson EM; Tang L; Kottilil S Clin Infect Dis; 2016 Jun; 62 Suppl 4(Suppl 4):S318-25. PubMed ID: 27190322 [TBL] [Abstract][Full Text] [Related]
17. Emerging pipeline drugs for hepatitis B infection. Cox N; Tillmann H Expert Opin Emerg Drugs; 2011 Dec; 16(4):713-29. PubMed ID: 22195605 [TBL] [Abstract][Full Text] [Related]
18. New therapies for chronic hepatitis B. Bitton Alaluf M; Shlomai A Liver Int; 2016 Jun; 36(6):775-82. PubMed ID: 26854115 [TBL] [Abstract][Full Text] [Related]
19. Immune balance in Hepatitis B Infection: Present and Future Therapies. Vyas AK; Jindal A; Hissar S; Ramakrishna G; Trehanpati N Scand J Immunol; 2017 Jul; 86(1):4-14. PubMed ID: 28387980 [TBL] [Abstract][Full Text] [Related]